Want to join the conversation?
$ENDP's US Branded business delivered sales of $305MM, while US Generics business posted sales of $368MM contributing to YTD total growth of 32% vs. the prior year. International Pharmaceutical business is meeting the company's expectations and the strategic portfolio of this business is continuing.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.